Acuamark Diagnostics, Announces Change to Its Board of Directors
July 23, 2020
July 22, 2020
Acuamark Diagnostics, Announces Change to Its Board of Directors
NEW YORK — July 21, 2020 — Acuamark Diagnostics, Inc. (“AcuamarkDx”), a biotechnology company that focuses on developing innovative blood-based screening assays for reliable and cost-effective detection of early-stage cancer, today announced the appointment of William Gedale as its Executive Chairman. Mr. Gedale will replace Mr. Michael Gargano as Chairman of the Company.
RELATED NEWS
- Surf ATL Selects Commenda Real Estate to Assist its Efforts to Develop the First Surfing-Based Outdoor Adventure Park in Georgia
- USAntibiotics Reopens Facility and Returns Antibiotic Production to the United States from China
- Trans Ocean Network Partnering With Ocean Networks for Caribbean Express
- Jackson Healthcare Saves Only U.S. Antibiotic Manufacturer of Amoxicillin; Purchases Out of Bankruptcy
- Breakthrough mobility and therapeutic device receives landmark FDA Clearance – introducing the MAC System
